ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,001 | 67.06396 | 1 | female | 0 | 10 | 194 | COPD | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 15,291 | 7,507.1133 | null | 18 | hispanic | 23 | 37 | 0.819946 | 0.706909 | 1 | 1 | 0 | no | 0.5 | 0.3 | no dnr | 10 | 62 | 11.5 | 68 | 16 | 36.79688 | 392 | null | 0.399963 | 4.399414 | 133 | 7.339844 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
2,002 | 76.28497 | 1 | male | 0 | 10 | 1,335 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 0 | 12,633 | 6,874.457 | null | 12 | white | 19.5 | 39 | 0.830933 | 0.773926 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 10 | 58 | 13.099609 | 60 | 24 | 36.59375 | 285.6875 | 2.299805 | 0.599976 | 1.5 | 139 | 7.319336 | null | null | null | 3 | 3 | adl>=4 (>=5 if sur) | 3 |
2,003 | 95.58099 | 1 | male | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 4 | under $11k | 26 | 27,548 | 17,302.7969 | null | 10.333328 | black | 24.898438 | 50 | 0.463989 | 0.344971 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 22 | 58 | 4 | 78 | 30 | 34.89844 | 416.625 | 2.099609 | 0.299988 | 1.399902 | 144 | 7.429688 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
2,004 | 60.79398 | 1 | male | 0 | 25 | 323 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 26,174 | 17,180.8281 | null | 12.333328 | black | 24.5 | 32 | 0.822998 | 0.711914 | 1 | 1 | 0 | no | null | null | dnr after sadm | 1 | 80 | 6.099609 | 100 | 25 | 35.59375 | null | null | null | 1.899902 | 149 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,005 | 52.28497 | 1 | male | 0 | 7 | 617 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 10,612 | 7,649.7734 | null | 21 | white | 21.597656 | 27 | 0.898926 | 0.830933 | 1 | 1 | 0 | no | 0.95 | 0.9 | no dnr | 7 | 104 | 17.398438 | 101 | 28 | 36.29688 | 257.125 | null | null | 0.699951 | 138 | 7.389648 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,006 | 58.32199 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 0 | 75,398 | 51,512.75 | null | 15.666664 | white | 20.597656 | 22 | 0.814941 | 0.75293 | 27 | 0 | 0 | no | 0.6 | 0.45 | dnr after sadm | 4 | 55 | 10.5 | 58 | 24 | 38.79688 | null | null | null | 1.099854 | 133 | 7.369141 | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
2,007 | 83.46899 | 1 | female | 0 | 7 | 76 | COPD | COPD/CHF/Cirrhosis | 1 | 14 | $11-$25k | 9 | 7,015 | 4,895.7891 | null | 11 | white | 21 | 22 | 0.710938 | 0.55188 | 1 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 1 | 107 | 6.699219 | 60 | 25 | 35.59375 | 404.3125 | null | null | 0.599976 | 138 | 7.399414 | null | null | null | 1 | 0 | adl>=4 (>=5 if sur) | 0 |
2,008 | 65.46997 | 1 | female | 1 | 142 | 142 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | $11-$25k | 0 | 216,883 | 123,592.312 | null | 33.75 | white | 28.398438 | 28 | 0.733887 | 0.651978 | 1 | 0 | 0 | no | 0.9 | 0.8 | dnr after sadm | 115 | 61 | 17 | 128 | 10 | 36 | 132.5 | 2.299805 | 0.899902 | 1 | 136 | 7.419922 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
2,009 | 77.008 | 0 | male | 0 | 8 | 1,690 | CHF | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 11,872 | 6,965.2148 | null | 9.5 | white | 18.296875 | 23 | 0.843994 | 0.743896 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 8 | 80 | 10.298828 | 80 | 20 | 35.59375 | 357.125 | null | null | 1.5 | 139 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,010 | 85.37195 | 1 | male | 1 | 9 | 9 | Coma | Coma | 1 | 16 | $25-$50k | 44 | 18,329 | 7,512.7578 | null | 31 | white | 31.097656 | 52 | 0.105988 | 0.064987 | 1 | 0 | 1 | no | 0.5 | 0.2 | dnr after sadm | 2 | 123 | 8.199219 | 136 | 34 | 38 | 84 | 3.399902 | 1 | 1.799805 | 143 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 4.395508 |
2,011 | 83.16199 | 1 | male | 0 | 14 | 29 | Lung Cancer | Cancer | 1 | 15 | null | 0 | 18,052 | 12,468.0547 | null | 8.333328 | white | 18.5 | 33 | 0.628906 | 0.317993 | 1 | 0 | 0 | metastatic | 0.4 | 0.3 | dnr after sadm | 1 | 123 | 6.5 | 110 | 20 | 36.39844 | 228 | null | null | 1.099854 | 136 | 7.459961 | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
2,012 | 65.91595 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 14,437 | 9,101.7734 | null | 38 | white | 54.695313 | 89 | 0.071991 | 0.025997 | 1 | 1 | 0 | no | null | null | dnr after sadm | 3 | 30 | 13.699219 | 0 | 0 | 38.79688 | 255 | null | null | 6.299805 | 137 | 7.289062 | null | null | null | null | null | <2 mo. follow-up | 2.091797 |
2,013 | 79.22498 | 1 | male | 0 | 9 | 1,453 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | $11-$25k | 0 | 12,608 | 8,627.8359 | null | 11.5 | white | 20.699219 | 25 | 0.805908 | 0.741943 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 9 | 103 | 5.299805 | 60 | 20 | 35.79688 | 328 | 2.5 | 0.599976 | 1.5 | 137 | 7.40918 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,014 | 78.09998 | 0 | male | 0 | 13 | 1,687 | COPD | COPD/CHF/Cirrhosis | 4 | 14 | null | 0 | 14,896 | 10,624.0078 | null | 8 | white | 21.597656 | 27 | 0.717896 | 0.56189 | 1 | 0 | 0 | yes | 0.7 | 0.2 | no dnr | 13 | 80 | 5.5 | 100 | 25 | 36.29688 | 147.5 | 3.899902 | null | 1.399902 | 140 | 7.339844 | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
2,015 | 59.88797 | 1 | female | 0 | 13 | 340 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 18 | null | 0 | 18,408 | 9,522.8906 | null | 18 | white | 30.699219 | 50 | 0.653931 | 0.554932 | 1 | 0 | 0 | yes | 0.8 | 0.04 | no dnr | 13 | 50 | 24.199219 | 74 | 12 | 36.29688 | null | 3.399902 | 0.5 | 3.099609 | 143 | null | null | null | null | 1 | 1 | SIP>=30 | 1 |
2,016 | 59.27197 | 0 | female | 0 | 9 | 1,683 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 9,120 | 6,131.0703 | null | 6 | white | 15.298828 | 26 | 0.91394 | 0.85498 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 9 | 73 | 7.899414 | 70 | 20 | 36.09375 | 304.75 | 3.699707 | 1.099854 | 1.399902 | 143 | 7.419922 | null | null | null | 2 | 1 | SIP>=30 | 1 |
2,017 | 63.25299 | 1 | male | 0 | 3 | 43 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 4,324 | 2,529.5195 | null | 9 | white | 29.296875 | 24 | 0.582886 | 0.262939 | 1 | 0 | 0 | metastatic | 0.3 | 0.2 | no dnr | 3 | 103 | 10.599609 | 100 | 20 | 36.69531 | null | 3.199707 | 6.399414 | 0.699951 | 131 | null | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
2,018 | 69.125 | 1 | female | 0 | 6 | 765 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 6,270 | 4,137.7578 | null | 14 | white | 21.097656 | 29 | 0.836914 | 0.73291 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 6 | 113 | 6.5 | 70 | 20 | 36.69531 | 396 | null | null | 4 | 136 | 7.329102 | null | null | null | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
2,019 | 71.461 | 1 | female | 0 | 7 | 266 | Lung Cancer | Cancer | 1 | 23 | $25-$50k | 0 | 9,665 | 6,271.7461 | null | 13 | white | 21.398438 | 27 | 0.591919 | 0.272949 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 7 | 107 | 8.298828 | 108 | 32 | 37.89844 | null | 3.099609 | 0.5 | 1.099854 | 139 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,020 | 87.24194 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | under $11k | 0 | 18,381 | 6,058.1445 | null | 27.5 | white | 29.199219 | 56 | 0.605957 | 0.5 | 1 | 0 | 1 | no | 0.5 | 0.4 | dnr after sadm | 2 | 47 | 9.599609 | 66 | 10 | 37.69531 | 220 | 2.699707 | 0.699951 | 4.299805 | 142 | 7.269531 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
2,021 | 57.79898 | 0 | male | 0 | 55 | 1,681 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 129,188 | 48,944.9688 | null | 33 | white | 33.09375 | 26 | 0.567993 | 0.455994 | 3 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 55 | 49 | 15.798828 | 50 | 10 | 38.09375 | 155 | null | 0.399963 | 0.599976 | 130 | 7.399414 | null | null | null | null | null | no(M2 and SIP pres) | 2.171875 |
2,022 | 72.62695 | 1 | male | 0 | 11 | 1,643 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 15,794 | 7,943.2148 | null | 14.5 | white | 22.796875 | 34 | 0.787964 | 0.659912 | 1 | 0 | 0 | no | 0.95 | 0.7 | dnr after sadm | 6 | 130 | 11.199219 | 109 | 40 | 36.69531 | 416 | null | null | 1.299805 | 134 | 7.369141 | null | null | null | 1 | 0 | SIP>=30 | 0 |
2,023 | 69.21594 | 1 | male | 0 | 5 | 422 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 5,314 | 3,484.1719 | null | 8 | white | 20.199219 | 45 | 0.846924 | 0.747925 | 1 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 5 | 73 | 7.199219 | 80 | 25 | 37.19531 | 248 | null | 0.699951 | 2.899902 | 137 | 7.459961 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,024 | 49.87299 | 1 | female | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 1 | 14 | null | 0 | 35,115 | 16,667.8594 | null | 36 | white | 41.898438 | 38 | 0.091995 | 0.036995 | 10 | 0 | 0 | metastatic | 0.3 | 0.2 | dnr after sadm | 7 | 43 | 2.699707 | 128 | 32 | 35.89844 | 205 | 2.5 | 0.599976 | 0.599976 | 136 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 2.51416 |
2,025 | 81.19098 | 0 | male | 0 | 61 | 1,676 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 7 | $25-$50k | 0 | 68,286 | 44,503.1875 | null | 15.5 | white | 24.796875 | 48 | 0.730957 | 0.647949 | 1 | 1 | 0 | no | 0.9 | 0.6 | no dnr | 61 | 57 | 7.099609 | 51 | 24 | 37.89844 | 496 | 2.5 | 0.399963 | 3.599609 | 150 | 7.459961 | null | null | null | 1 | null | SIP>=30 | 1.1669 |
2,026 | 50.19598 | 0 | female | 0 | 23 | 1,676 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 2 | >$50k | 0 | 31,479 | 20,222.6562 | null | 11.666664 | white | 28.898438 | 33 | 0.698975 | 0.534912 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 23 | 103 | 12.199219 | 80 | 20 | 36.09375 | null | 3.699707 | 0.699951 | 3.799805 | 125 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
2,027 | 69.12299 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 10 | null | 0 | 53,798 | 40,329.6875 | null | 36 | white | 26.199219 | 48 | 0.719971 | 0.633911 | 4 | 1 | 0 | no | 0.8 | 0.7 | dnr after sadm | 8 | 110 | 6.699219 | 70 | 12 | 38.29688 | 107.14062 | null | null | 6.199219 | 142 | 7.429688 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
2,028 | 82.35699 | 1 | female | 0 | 241 | 1,231 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 209,565 | 143,218.5 | null | 11 | black | 17.898438 | 27 | 0.766968 | 0.692993 | 1 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 1 | 137 | 21.898438 | 100 | 20 | 37.79688 | 323.75 | 3.599609 | 1 | 1.199951 | 135 | 7.399414 | null | null | null | null | null | null | 3.057617 |
2,029 | 52.57797 | 1 | female | 0 | 7 | 118 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 11 | under $11k | 0 | 7,638 | 5,049.6445 | null | 4 | white | 15.898438 | 27 | 0.873901 | 0.790894 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 7 | 67 | 6.799805 | 70 | 15 | 37 | 180.9375 | 2.799805 | 0.799927 | 1.099854 | 138 | 7.379883 | null | null | null | 1 | null | null | 1.1669 |
2,030 | 71.79498 | 1 | male | 0 | 25 | 97 | COPD | COPD/CHF/Cirrhosis | 2 | 18 | $11-$25k | 0 | 46,839 | 22,876.9062 | null | 28 | white | 23.199219 | 13 | 0.787964 | 0.659912 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 10 | 61 | 11.199219 | 68 | 10 | 37.69531 | 152.5 | 3.199707 | 0.699951 | 0.699951 | 136 | 7.419922 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
2,031 | 38.66699 | 0 | female | 0 | 21 | 1,670 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 9 | null | 0 | 46,790 | 20,298.0625 | null | 41 | black | 43.796875 | 63 | 0.424988 | 0.224976 | 1 | 0 | 0 | no | 0.4 | 0.4 | no dnr | 21 | 43 | 29.097656 | 43 | 8 | 35.59375 | 217 | 2.399902 | 11.099609 | 0.5 | 137 | 7.359375 | null | null | null | null | 0 | null | 0 |
2,032 | 77.85394 | 1 | female | 0 | 7 | 902 | COPD | COPD/CHF/Cirrhosis | 0 | 17 | null | 9 | 8,190 | 5,374.0156 | null | 11 | white | 15.599609 | 24 | 0.834961 | 0.72998 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 7 | 63 | 7.899414 | 80 | 20 | 36.69531 | 261.875 | null | null | 0.799927 | 133 | 7.369141 | null | null | null | null | null | null | 2.091309 |
2,033 | 70.45898 | 0 | female | 0 | 14 | 1,669 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | $25-$50k | 0 | 21,065 | 11,537.9062 | null | 14.666664 | white | 16.5 | 36 | 0.878906 | 0.835938 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 14 | 61 | 8.898438 | 65 | 36 | 38.29688 | 256.625 | 3 | 1.199951 | 1.5 | 137 | 7.359375 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,034 | 77.435 | 1 | male | 1 | 4 | 4 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 5,085 | 3,324.0449 | null | 12 | white | 26.097656 | 39 | 0.691895 | 0.526978 | 1 | 0 | 1 | no | 0.5 | 0.25 | dnr after sadm | 1 | 77 | 7.599609 | 120 | 40 | 39.09375 | 140 | null | null | 0.899902 | 139 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 5.772461 |
2,035 | 83.30194 | 1 | female | 0 | 12 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | null | 9 | 25,474 | 18,161.7188 | null | 33.5 | white | 25.398438 | 60 | 0.656982 | 0.55896 | 2 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 12 | 59 | 14.599609 | 160 | 24 | 38.5 | 256.625 | null | 0.699951 | 2.399902 | 141 | 7.369141 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,036 | 77.42896 | 1 | male | 1 | 39 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 93,900 | 58,769.0312 | null | 23.75 | null | 35.09375 | 55 | 0.376953 | 0.258972 | 32 | 1 | 0 | no | 0.7 | 0.5 | dnr after sadm | 32 | 49 | 16.398438 | 131 | 32 | 36.39844 | 187.75 | 2.099609 | 0.799927 | 1.299805 | 155 | 7.379883 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
2,037 | 90.57599 | 1 | female | 1 | 9 | 9 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 9,106 | 6,112.6406 | null | 14 | white | 20.796875 | 35 | 0.754883 | 0.612915 | 1 | 0 | 0 | no | 0.95 | 0.85 | dnr after sadm | 3 | 73 | 5.5 | 60 | 25 | 35.39844 | null | 3.699707 | null | 1.699951 | 142 | null | null | null | null | null | null | <2 mo. follow-up | 3.70752 |
2,038 | 54.237 | 1 | female | 0 | 3 | 722 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 9 | 3,979 | 2,404.7246 | null | 6 | white | 23.296875 | 28 | 0.744995 | 0.5979 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 80 | 6.599609 | 80 | 20 | 36.39844 | 504.75 | 2.099609 | 6.5 | 0.799927 | 129 | 7.449219 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,039 | 83.10199 | 0 | male | 0 | 4 | 1,663 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | null | 0 | 3,464 | 2,371.1113 | null | 2 | white | 19.199219 | 22 | 0.766968 | 0.629883 | 1 | 0 | 0 | yes | null | null | no dnr | 4 | 117 | 5 | 50 | 20 | 36.69531 | 336.625 | null | null | 1.699951 | 141 | 7.429688 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,040 | 66.92096 | 0 | female | 0 | 8 | 1,661 | COPD | COPD/CHF/Cirrhosis | 1 | 16 | >$50k | 0 | 13,139 | 6,770.543 | null | 16.5 | white | 30.097656 | 31 | 0.701904 | 0.539917 | 1 | 0 | 0 | no | 0.98 | 0.9 | no dnr | 8 | 56 | 6.599609 | 109 | 8 | 37.89844 | 180 | 2.399902 | null | 0.599976 | 141 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,041 | 73.487 | 1 | female | 0 | 7 | 14 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 8,837 | 5,661.6797 | null | 7.5 | black | 19 | 14 | 0.769897 | 0.522949 | 1 | 0 | 0 | metastatic | 0.2 | 0 | dnr before sadm | -1 | 109 | 9.5 | 72 | 20 | 36.09375 | null | 2.5 | 0.399963 | 1 | 134 | null | null | null | null | 4 | 2 | <2 mo. follow-up | 2 |
2,042 | 66.52399 | 1 | female | 0 | 15 | 230 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 26,499 | 10,231.5625 | null | 25 | black | 37.59375 | 56 | 0.248993 | 0.145996 | 1 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 1 | 49 | 11.798828 | 129 | 40 | 38.59375 | 175 | 4.099609 | 2.5 | 1.699951 | 147 | 7.479492 | null | null | null | null | null | no(M2 and SIP pres) | 2.737793 |
2,043 | 41.12299 | 1 | male | 0 | 59 | 897 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 61 | 78,089 | 47,791.0625 | null | 16.5 | black | 22 | 33 | 0.730957 | 0.647949 | 3 | 0 | 0 | no | 0.25 | 0.25 | dnr after sadm | 5 | 121 | 13.699219 | 63 | 32 | 39.29688 | 416.625 | 2 | 1.5 | 2 | 142 | 7.449219 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
2,044 | 64.81299 | 1 | male | 0 | 9 | 29 | CHF | COPD/CHF/Cirrhosis | 0 | 10 | under $11k | 0 | 12,726 | 8,069.832 | null | 16.5 | white | 30.199219 | 46 | 0.712891 | 0.554932 | 1 | 0 | 0 | no | 0.5 | 0.2 | dnr after sadm | 7 | 70 | 8.699219 | 60 | 20 | 35.59375 | 323.75 | null | null | 5.199219 | 125 | 7.259766 | null | null | null | 2 | null | <2 mo. follow-up | 1.839 |
2,045 | 82.15698 | 1 | female | 0 | 26 | 116 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 40,355 | 18,819.2812 | null | 20 | white | 23.097656 | 50 | 0.758911 | 0.681885 | 1 | 1 | 0 | no | 0.7 | 0.5 | dnr after sadm | 6 | 59 | 5.399414 | 60 | 26 | 37.69531 | 276.625 | 3.699707 | null | 2.199707 | 142 | 7.449219 | null | null | null | 4 | 6 | adl>=4 (>=5 if sur) | 6 |
2,046 | 83.16199 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 19 | null | 0 | 13,316 | 8,379.6406 | null | 57 | white | 42.398438 | 65 | 0.256958 | 0.151978 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 43 | 9.5 | 120 | 38 | 38.39844 | 123.32812 | 4.099609 | 1.099854 | 2.599609 | 141 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 2.83252 |
2,047 | 68.19995 | 0 | female | 0 | 43 | 1,652 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | >$50k | 0 | 83,351 | 57,514.5 | null | 32.5 | white | 38.09375 | 63 | 0.487976 | 0.369995 | 1 | 0 | 0 | no | 0.05 | 0.000125 | no dnr | 43 | 49 | 8.398438 | 145 | 10 | 38.59375 | 105 | 3.299805 | 0.699951 | 3.299805 | 137 | 7.369141 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.031738 |
2,048 | 47.58899 | 1 | male | 0 | 7 | 190 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 10 | $25-$50k | 0 | 6,175 | 4,326.5781 | null | 9 | white | 20.199219 | 19 | 0.848999 | 0.750977 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 7 | 80 | 5.299805 | 80 | 20 | 37 | null | null | 5 | 0.799927 | 131 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,049 | 74.05896 | 0 | female | 0 | 10 | 1,650 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 9,658 | 6,682.3438 | null | 8 | white | 29.398438 | 40 | 0.542969 | 0.219971 | 1 | 0 | 0 | metastatic | 0.7 | 0.3 | no dnr | 10 | 100 | 6.799805 | 80 | 20 | 36.09375 | null | 2.699707 | 2.799805 | 10.398438 | 135 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,050 | 64.83496 | 1 | female | 1 | 9 | 9 | Coma | Coma | 0 | 18 | $11-$25k | 89 | 14,380 | 5,589.5703 | null | 12.5 | asian | 19.699219 | 23 | 0.387939 | 0.314941 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 3 | 56 | 9.798828 | 47 | 6 | 38.09375 | 393.3125 | 2.599609 | null | 0.799927 | 136 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,051 | 34.51297 | 1 | male | 0 | 61 | 1,232 | Coma | Coma | 2 | 12 | null | 0 | 123,827 | 33,595.5938 | null | 23 | white | 28.5 | 51 | 0.690918 | 0.636963 | 7 | 0 | 0 | yes | 1 | 1 | no dnr | 61 | 57 | 2 | 58 | 12 | 33.5 | 178 | 2.299805 | null | 1.399902 | 142 | 7.40918 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
2,052 | 85.54999 | 1 | male | 0 | 11 | 105 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 26 | 11,059 | 8,758.3984 | null | 11 | white | 26.796875 | 39 | 0.553955 | 0.356995 | 1 | 0 | 0 | no | 0.8 | 0.6 | dnr after sadm | 1 | 63 | 8.599609 | 66 | 24 | 35.59375 | 319 | null | null | 3.199707 | 129 | 7.449219 | null | null | null | null | null | no(M2 and SIP pres) | 4.527344 |
2,053 | 75.10999 | 0 | male | 0 | 17 | 1,645 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 17,967 | 12,273.4141 | null | 8.333328 | white | 24.898438 | 24 | 0.651978 | 0.346985 | 1 | 0 | 0 | metastatic | 1 | 0.6 | no dnr | 17 | 80 | 5.299805 | 60 | 25 | 38.89844 | null | 2.899902 | 1 | 1.299805 | 132 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,054 | 70.25098 | 0 | male | 0 | 10 | 1,642 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 21,914 | 15,529.125 | null | 28 | white | 26.898438 | 36 | 0.678955 | 0.508911 | 1 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 10 | 57 | 17.5 | 117 | 8 | 38.29688 | 125 | null | null | 1.199951 | 139 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,055 | 80.35895 | 0 | female | 0 | 6 | 1,642 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 6,528 | 4,329.5859 | null | 12 | white | 16.097656 | 35 | 0.823975 | 0.713989 | 1 | 0 | 0 | yes | 1 | 0.9 | no dnr | 6 | 70 | 4.299805 | 80 | 35 | 37 | 211.09375 | null | null | 1.099854 | 140 | 7.40918 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
2,056 | 52.10397 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $25-$50k | 0 | 18,313 | 8,718.0938 | null | 49 | white | 33 | 62 | 0.470947 | 0.35199 | 2 | 0 | 0 | yes | 0.2 | 0.1 | dnr after sadm | 4 | 60 | 0.099991 | 120 | 8 | 36.59375 | 182.84375 | 2.199707 | null | 1.699951 | 138 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,057 | 83.461 | 1 | male | 1 | 87 | 87 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 20 | $25-$50k | 0 | 177,467 | 141,714.75 | null | 37.25 | white | 46.09375 | 71 | 0.158997 | 0.077988 | 1 | 1 | 0 | no | 0 | 0 | dnr after sadm | 87 | 43 | 3.199707 | 120 | 32 | 36.5 | 231.65625 | 2.199707 | 0.799927 | 2.899902 | 128 | 7.319336 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
2,058 | 75.33197 | 1 | female | 1 | 38 | 38 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | $11-$25k | 0 | 88,774 | 49,328.5625 | null | 18.25 | white | 28.398438 | 37 | 0.588989 | 0.480957 | 21 | 1 | 0 | no | 0.9 | 0.9 | dnr after sadm | 24 | 64 | 19.5 | 110 | 26 | 36.09375 | 253.03125 | null | 0.399963 | 1.399902 | 126 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,059 | 84.47894 | 0 | male | 0 | 11 | 1,637 | COPD | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 12,504 | 8,726.3828 | null | 10.5 | white | 17.097656 | 29 | 0.750977 | 0.606934 | 1 | 0 | 0 | yes | 0.75 | 0.5 | no dnr | 11 | 105 | 10.199219 | 68 | 24 | 36.89844 | null | null | 0.5 | 1.799805 | 138 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 4.250977 |
2,060 | 85.48096 | 1 | female | 0 | 5 | 1,096 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 5,872 | 3,718.6934 | null | 8 | white | 17.097656 | 23 | 0.792969 | 0.666992 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 5 | 67 | 21.296875 | 70 | 20 | 36.69531 | 332 | null | null | 1.299805 | 144 | 7.339844 | null | null | null | 3 | null | null | 2.511099 |
2,061 | 64.06 | 1 | female | 0 | 3 | 93 | Lung Cancer | Cancer | 1 | 14 | $11-$25k | 0 | 4,562 | 3,148.3848 | null | 11 | white | 13 | 18 | 0.781982 | 0.542969 | 1 | 0 | 0 | metastatic | null | null | no dnr | 3 | 75 | 7.799805 | 100 | 18 | 36.89844 | null | 3.899902 | 0.399963 | 0.699951 | 134 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,062 | 55.896 | 1 | female | 1 | 33 | 33 | Colon Cancer | Cancer | 1 | 14 | null | 0 | 39,582 | 26,151.2344 | null | 14 | null | 7.799805 | 19 | 0.916992 | 0.806885 | 1 | 0 | 0 | metastatic | 0.95 | 0.7 | dnr before sadm | 0 | 127 | 8.099609 | 60 | 22 | 37.69531 | null | 4.099609 | 0.399963 | 1.399902 | 139 | null | null | null | null | null | 5 | <2 mo. follow-up | 5 |
2,063 | 65.29797 | 1 | male | 0 | 13 | 30 | Colon Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 13,669 | 9,362.3203 | null | 13.5 | white | 16.5 | 12 | 0.823975 | 0.61792 | 1 | 0 | 0 | metastatic | 0.5 | 0.15 | dnr after sadm | 5 | 60 | 12.298828 | 90 | 20 | 36.69531 | null | null | null | 0.799927 | 140 | null | null | null | null | null | 2 | <2 mo. follow-up | 2 |
2,064 | 80.77496 | 1 | female | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 0 | 82,763 | 62,808.2188 | null | 26.666656 | white | 23.796875 | 41 | 0.5979 | 0.490967 | 20 | 0 | 0 | yes | 0.2 | 0.05 | dnr after sadm | 4 | 53 | 18.597656 | 73 | 22 | 38.39844 | 383.3125 | null | 0.899902 | 7.399414 | 139 | 7.359375 | null | null | null | 6 | 6 | <2 mo. follow-up | 6 |
2,065 | 74.46698 | 1 | female | 1 | 36 | 36 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 9 | 46,365 | 32,123.8594 | null | 14 | null | 39.59375 | 54 | 0.122986 | 0.054993 | 2 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 3 | 47 | 3.399902 | 154 | 52 | 36.29688 | 284 | null | null | 0.599976 | 139 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 3.837402 |
2,066 | 74.875 | 1 | female | 0 | 15 | 81 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 18 | under $11k | 0 | 18,145 | 9,994.9297 | null | 10.333328 | black | 17 | 31 | 0.863892 | 0.816895 | 1 | 1 | 0 | no | 0.8 | 0.3 | no dnr | 15 | 62 | 7.099609 | 70 | 32 | 37.89844 | 620 | 4.199219 | null | 0.899902 | 154 | 7.379883 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
2,067 | 46.448 | 0 | male | 0 | 93 | 1,629 | Coma | Coma | 0 | null | null | 0 | 102,951 | 61,589.5312 | null | 32 | white | 43.398438 | 46 | 0.343994 | 0.270996 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 5 | 39 | 8.798828 | 130 | 8 | 34 | 162.5 | 2.599609 | null | 0.799927 | 144 | 7.379883 | null | null | null | null | null | null | 1.659912 |
2,068 | 36.36099 | 0 | male | 0 | 19 | 1,631 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 0 | 49,378 | 20,026.4531 | null | 27.666656 | white | 27.097656 | 49 | 0.819946 | 0.758911 | 6 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 19 | 57 | 8.5 | 100 | 34 | 39.29688 | 171.65625 | 2.299805 | 5 | 0.799927 | 148 | 7.439453 | null | null | null | 4 | 3 | no(M2 and SIP pres) | 3 |
2,069 | 84.758 | 1 | female | 0 | 16 | 201 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 55,554 | 41,568.0312 | null | 24 | white | 16.597656 | 32 | 0.753906 | 0.610962 | 8 | 0 | 0 | no | 0.9 | 0.9 | dnr after sadm | 1 | 70 | 5.799805 | 100 | 9 | 37.89844 | 343 | null | null | 1 | 132 | 7.449219 | null | null | null | null | null | null | 3.980957 |
2,070 | 73.09497 | 1 | male | 0 | 4 | 629 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 3,231 | 2,033.0977 | null | 9 | white | 8.898438 | 19 | 0.924927 | 0.872925 | 1 | 0 | 1 | no | 0.9 | 0.8 | no dnr | 4 | 110 | 9.298828 | 60 | 20 | 37 | 324 | 4.399414 | 0.299988 | 1.099854 | 140 | 7.379883 | null | null | null | null | null | null | 4.662109 |
2,071 | 87.836 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 100 | 7,485 | 2,813.8379 | null | 21 | white | 20.796875 | 42 | 0.340942 | 0.224976 | 1 | 1 | 0 | no | 0 | 0 | dnr after sadm | 3 | 57 | 14.298828 | 111 | 14 | 37.89844 | 376.625 | 3.799805 | null | 1.199951 | 139 | 7.469727 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
2,072 | 65.21796 | 1 | male | 1 | 17 | 17 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 56,488 | 25,246.2031 | null | 45 | white | 42.796875 | 67 | 0.173981 | 0.047997 | 1 | 0 | 0 | no | null | null | dnr after sadm | 6 | 45 | 11.398438 | 120 | 8 | 37.69531 | 104 | 2.399902 | 1.899902 | 2.899902 | 136 | 7.339844 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,073 | 39.159 | 1 | male | 1 | 6 | 6 | Lung Cancer | Cancer | 2 | 14 | $11-$25k | 0 | 8,814 | 5,570.7383 | null | 27 | white | 48.59375 | 56 | 0.029999 | 0 | 1 | 0 | 0 | metastatic | 0.01 | 0.000001 | dnr after sadm | 3 | 52 | 31.097656 | 140 | 28 | 38.19531 | 121.65625 | 1.899902 | 0.5 | 0.599976 | 139 | 7.449219 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
2,074 | 61.23999 | 1 | female | 1 | 28 | 28 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 104,725 | 64,707.5 | null | 48.75 | black | 15.798828 | 21 | 0.820923 | 0.708984 | 3 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 28 | 129 | 6.799805 | 70 | 16 | 36.09375 | null | 2.199707 | null | 0.799927 | 143 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
2,075 | 85.05396 | 1 | male | 0 | 156 | 420 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 44 | 143,520 | 94,672.4375 | null | 20 | white | 31.296875 | 57 | 0.340942 | 0.224976 | 1 | 1 | 1 | no | 0.65 | 0.5 | dnr after sadm | 1 | 50 | 6.599609 | 48 | 37 | 38.09375 | 237.5 | null | null | 3 | 144 | 7.30957 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
2,076 | 80.54999 | 1 | female | 0 | 27 | 59 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | null | 0 | 51,714 | 39,208.5 | null | 20.5 | white | 26.097656 | 53 | 0.633911 | 0.531982 | 10 | 1 | 0 | no | 0.9 | 0.8 | dnr after sadm | 1 | 63 | null | 39 | 28 | 36.09375 | null | null | null | 2.099609 | 134 | null | null | null | null | null | 4 | <2 mo. follow-up | 4 |
2,077 | 73.30298 | 1 | male | 1 | 45 | 45 | COPD | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 73,250 | 31,503.1719 | null | 22.75 | white | 25 | 43 | 0.689941 | 0.522949 | 1 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 32 | 57 | 9.099609 | 132 | 38 | 36.5 | 250 | null | null | 0.699951 | 137 | 7.379883 | null | null | null | null | null | <2 mo. follow-up | 2.676758 |
2,078 | 66.89899 | 1 | female | 1 | 33 | 33 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | null | 37 | 87,649 | 76,678.5625 | null | 39.75 | white | 31.199219 | 52 | 0.478943 | 0.360962 | 2 | 1 | 0 | no | 0.7 | 0.7 | no dnr | 33 | 130 | 11.898438 | 110 | 24 | 39.09375 | 138 | null | null | 3 | 145 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,079 | 62.04498 | 0 | male | 0 | 23 | 1,621 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 102,951 | 18,028.2969 | null | 18.666656 | white | 18.796875 | 39 | 0.881958 | 0.802979 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 23 | 77 | 9.199219 | 80 | 25 | 36.69531 | 203.3125 | 3.199707 | 0.799927 | 1.199951 | 135 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,080 | 91.00098 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 25,116 | 12,177.7344 | null | 40 | white | 46.398438 | 53 | 0.051994 | 0.016998 | 12 | 0 | 0 | no | 0.3 | 0.15 | dnr after sadm | 2 | 41 | 17.796875 | 67 | 27 | 35.69531 | 320 | null | null | 2.799805 | 121 | 7.469727 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
2,081 | 70.86694 | 1 | female | 0 | 13 | 1,269 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 20,128 | 14,848.0938 | null | 26 | white | 24.5 | 22 | 0.778931 | 0.706909 | 1 | 0 | 0 | no | 0.85 | 0.75 | no dnr | 13 | 57 | 10.599609 | 52 | 22 | 39.29688 | 171.40625 | 2.5 | 1.899902 | 0.799927 | 139 | 7.439453 | null | null | null | 0 | null | null | 0.4948 |
2,082 | 80.80798 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 0 | 21,600 | 16,596.6094 | null | 42.5 | white | 47.398438 | 90 | 0.058998 | 0.019997 | 2 | 0 | 0 | yes | 0.04 | 0.000064 | dnr after sadm | 6 | 40 | 99 | 174 | 48 | 36.29688 | 95 | 2.099609 | null | 1.399902 | 146 | 7.469727 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,083 | 39.01398 | 0 | male | 0 | 54 | 1,619 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 0 | 143,863 | 52,669.7188 | null | 39.5 | white | 46.695313 | 75 | 0.440979 | 0.32196 | 1 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 54 | 47 | 12.5 | 120 | 46 | 36.59375 | 145 | 2.799805 | 4.699219 | 6.199219 | 134 | 7.40918 | null | null | null | null | 0 | null | 0 |
2,084 | 96.29297 | 1 | male | 0 | 11 | 327 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 23,315 | 14,476.0781 | null | 31 | white | 25.898438 | 35 | 0.557983 | 0.445984 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 11 | 115 | 3.599609 | 59 | 24 | 37.69531 | 409.5 | 3.199707 | null | 3.899902 | 138 | 7.379883 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,085 | 60.96399 | 0 | female | 0 | 7 | 1,616 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 7,831 | 5,228.7148 | null | 7 | white | 17 | 15 | 0.897949 | 0.829956 | 1 | 1 | 0 | no | 0.95 | 0.8 | no dnr | 7 | 60 | 10.699219 | 60 | 20 | 36.69531 | 360 | null | null | 1.199951 | 135 | 7.399414 | null | null | null | 4 | null | SIP>=30 | 3.183199 |
2,086 | 57.892 | 1 | male | 0 | 4 | 152 | Lung Cancer | Cancer | 2 | null | null | 0 | 3,803 | 2,349.0977 | null | 12 | black | 17.097656 | 21 | 0.721924 | 0.445984 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 4 | 71 | 4.799805 | 110 | 24 | 37.09375 | 266.625 | null | null | 1.099854 | 139 | 7.489258 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
2,087 | 79.43097 | 1 | female | 0 | 46 | 60 | Colon Cancer | Cancer | 2 | 19 | $11-$25k | 0 | 41,940 | 31,571.2969 | null | 3.25 | white | 28.097656 | 17 | 0.55896 | 0.235992 | 1 | 1 | 0 | metastatic | null | null | dnr after sadm | 1 | 87 | 5.299805 | 109 | 20 | 36.09375 | null | 2.899902 | 1 | 0.899902 | 131 | null | null | null | null | 0 | 5 | null | 5 |
2,088 | 84.25494 | 1 | male | 0 | 5 | 1,578 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 4,931 | 3,273.2148 | null | 9 | white | 17.796875 | 24 | 0.826904 | 0.717896 | 1 | 0 | 0 | no | 0.98 | 0.8 | no dnr | 5 | 73 | 9.599609 | 80 | 20 | 36.69531 | 392 | null | null | 1.899902 | 135 | 7.459961 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
2,089 | 62.97897 | 0 | male | 0 | 9 | 1,606 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 42,691 | 24,151.6406 | null | 11.5 | black | 23 | 18 | 0.783936 | 0.654907 | 19 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 9 | 125 | 14.699219 | 119 | 24 | 36.29688 | 292 | null | null | 0.599976 | 139 | 7.419922 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
2,090 | 75.34296 | 1 | male | 0 | 12 | 60 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 15,764 | 10,021.3438 | null | 12 | white | 11.298828 | 27 | 0.866943 | 0.701904 | 1 | 0 | 0 | metastatic | 0.5 | 0.125 | no dnr | 12 | 67 | 9.599609 | 80 | 20 | 40 | null | 3.799805 | null | 1.099854 | 138 | null | null | null | null | 1 | 1 | null | 1 |
2,091 | 65.20697 | 1 | female | 0 | 14 | 28 | MOSF w/Malig | ARF/MOSF | 1 | 13 | $25-$50k | 0 | 27,314 | 13,883.3828 | null | 31 | white | 45.5 | 61 | 0.125977 | 0.056999 | 1 | 0 | 0 | yes | 0.6 | 0.1 | dnr after sadm | 2 | 40 | 0.299988 | 180 | 22 | 35.59375 | 381.625 | 4 | 0.899902 | 0.699951 | 135 | 7.419922 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
2,092 | 75.45197 | 1 | male | 1 | 24 | 24 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | $25-$50k | 0 | 27,479 | 20,806.5469 | null | 19.666656 | white | 33.695313 | 68 | 0.564941 | 0.369995 | 1 | 1 | 0 | no | 0.9 | 0.8 | dnr after sadm | 20 | 44 | 8.699219 | 64 | 26 | 35.59375 | 276.1875 | null | 0.599976 | 2.599609 | 137 | 7.569336 | null | null | null | 0 | 2 | <2 mo. follow-up | 2 |
2,093 | 74.17096 | 0 | female | 0 | 5 | 1,604 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 24,406 | 16,957.9062 | null | 43 | white | 16.796875 | 14 | 0.844971 | 0.791992 | 4 | 0 | 0 | no | 0.3 | 0.2 | no dnr | 5 | 66 | 7.399414 | 60 | 10 | 38.79688 | 180 | 2.799805 | null | 1 | 143 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
2,094 | 55.31799 | 1 | female | 1 | 21 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 91,472 | 62,769.8438 | null | 41.333313 | white | 27.296875 | 33 | 0.753906 | 0.675903 | 5 | 0 | 0 | no | 0.75 | 0.7 | dnr after sadm | 21 | 66 | 15 | 51 | 10 | 39.09375 | 161.65625 | null | 1.5 | 2.299805 | 141 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
2,095 | 61.06998 | 0 | female | 0 | 10 | 1,599 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 37,517 | 25,528.4062 | null | 29 | white | 24.597656 | 29 | 0.796997 | 0.67395 | 5 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 10 | 67 | 12.898438 | 70 | 10 | 36.39844 | 118 | null | null | 0.599976 | 142 | 7.489258 | null | null | null | 0 | null | null | 0.4948 |
2,096 | 76.57996 | 1 | male | 0 | 17 | 44 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 0 | 46,322 | 35,720.125 | null | 26 | white | 37.695313 | 69 | 0.290955 | 0.181 | 4 | 0 | 0 | yes | 0.4 | 0.1 | no dnr | 17 | 56 | 15.298828 | 110 | 12 | 38.29688 | 170 | 2.899902 | 13.898438 | 3.099609 | 137 | 7.379883 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
2,097 | 91.47198 | 1 | female | 0 | 25 | 71 | MOSF w/Malig | ARF/MOSF | 2 | 17 | >$50k | 9 | 58,579 | 34,724.0312 | null | 22.333328 | white | 33 | 50 | 0.270996 | 0.163971 | 10 | 0 | 0 | yes | 0.3 | 0.2 | dnr after sadm | 9 | 53 | 1.599854 | 120 | 26 | 36.19531 | 390 | null | null | 1 | 138 | 7.5 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
2,098 | 22.31099 | 0 | male | 0 | 53 | 1,596 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 44 | 69,109 | 56,255.5 | null | 17 | white | 19.097656 | 15 | 0.868896 | 0.822998 | 4 | 0 | 0 | no | 0.2 | 0.5 | no dnr | 53 | 110 | 9.298828 | 120 | 10 | 39 | 434.6875 | null | null | 0.899902 | 135 | 7.449219 | null | null | null | null | 1 | null | 1 |
2,099 | 60.40799 | 0 | female | 0 | 11 | 1,598 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 0 | 26,252 | 17,970.7188 | null | 28 | white | 17 | 10 | 0.894897 | 0.856934 | 1 | 0 | 0 | no | 0.85 | 0.6 | no dnr | 11 | 63 | 11 | 96 | 12 | 37.89844 | 282.125 | 2.599609 | 0.899902 | 0.799927 | 138 | 7.359375 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
2,100 | 77.15497 | 1 | male | 0 | 19 | 33 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 84,411 | 47,659.9375 | null | 24 | white | 40.695313 | 59 | 0.21698 | 0.119995 | 33 | 0 | 0 | no | 0.5 | 0.125 | no dnr | 19 | 45 | 19.5 | 38 | 24 | 34.79688 | 200 | 2 | 1.899902 | 1.899902 | 146 | 7.489258 | null | null | null | 0 | 1 | <2 mo. follow-up | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.